No Data
Daan Gene: First quarter report 2025
Express News | Daan Gene Q1 Net Profit at 52.9 Mln Yuan
Daan Gene Co.,Ltd. (002030.SZ): Net income for the first quarter is 52.9243 million yuan.
On April 29, Gelonghui reported that Daan Gene Co.,Ltd. (002030.SZ) announced its Q1 2025 report, with revenue of 0.169 billion yuan, a year-on-year decrease of 14.71%; net income attributable to shareholders of the listed company was 52.9243 million yuan; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was -98.9607 million yuan; basic EPS was 0.04 yuan.
The impact of U.S. tariff policy on the company is relatively small. Daan Gene Co.,Ltd.: There is currently no plan for shareholding increase | Spotlight on Earnings Conference.
① During the Earnings Conference, Daan Gene Co.,Ltd. General Manager Huang Luo stated that the current diagnostic reagent industry is experiencing both an expansion in market size and intensified market competition. ② The company indicated that since overseas revenue accounts for a small proportion, the USA's tariff increases have a limited impact on the company, but there are currently no plans for Shareholding.
Individual Investors Are Daan Gene Co., Ltd.'s (SZSE:002030) Biggest Owners and Were Hit After Market Cap Dropped CN¥940m
Daan Gene: 2024 Annual Report Summary